Clinical trial
S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors…
NCT00352443 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00352443 |
|---|---|
| Title | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
| Official title | Phase I Study Evaluating the Combination of Lapatinib (GW572016; NSC-727989) and Everolimus (RAD001) in Patients With Advanced Solid Tumors |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | everolimus, lapatinib ditosylate |
| Enrollment | 66 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 1, 2013 |
| First posted | Jul 14, 2006 |
| Last update posted | Mar 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: